Skip to main content
OpenTrials

Clinical trial condition

Immunologic Deficiency Syndromes

Explore clinical trials studying Immunologic Deficiency Syndromes. Study availability and eligibility vary by location and protocol.

6,132 public trials 395 recruiting studies
Refine in advanced search Browse all conditions

Immunologic Deficiency Syndromes trial results

Completed

Prophylaxis Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Suspected Latent Tuberculous Infection

NCT00000959

Conditions
AIDS-Related Opportunistic Infections, Acquired Immunodeficiency Syndrome, Actinomycetales Infections, +21 more
Locations
  • UCLA Med Ctr Los Angeles, California, United States
  • Community Consortium of San Francisco San Francisco, California, United States
  • Denver CPCRA / Denver Public Hlth Denver, Colorado, United States
  • Hill Health Corp New Haven, Connecticut, United States
View all 14 locations
View Trial Details
Completed

A Phase I, Multicenter, Randomized Trial to Evaluate the Safety and Immunogenicity of a Recombinant Vaccinia-HIV Envelope Vaccine (HIVAC-1e) in Combination With a Panel of Subunit Recombinant HIV Envelope Vaccines in Vaccinia-Naive Individuals

NCT00001026

Conditions
Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +14 more
Locations
  • Univ. of Rochester AVEG Rochester, New York, United States
  • UW - Seattle AVEG Seattle, Washington, United States
View Trial Details
Completed

Gradual Initiation of Sulfamethoxazole/Trimethoprim as Primary Pneumocystis Carinii Pneumonia Prophylaxis

NCT00000816

Conditions
AIDS-Related Complex, Acquired Immunodeficiency Syndrome, Bacterial Infections and Mycoses, +24 more
Locations
  • USC CRS Los Angeles, California, United States
  • Stanford CRS Palo Alto, California, United States
  • Ucsf Aids Crs San Francisco, California, United States
  • Santa Clara Valley Med. Ctr. San Jose, California, United States
View all 42 locations
View Trial Details
Completed

Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women

NCT00604175

Conditions
Blood-Borne Infections, Communicable Diseases, Disease Attributes, +14 more
Locations
  • Alabama Therapeutics CRS Birmingham, Alabama, United States
  • Usc La Nichd Crs Alhambra, California, United States
  • University of California, UC San Diego CRS La Jolla, California, United States
  • Miller Children's Hosp. Long Beach CA NICHD CRS Long Beach, California, United States
View all 61 locations
View Trial Details
Completed

A Multicenter, Double Blind, Comparative Study of Zidovudine Alone Versus Zidovudine and Acyclovir as Treatment for HIV-Infected Patients With CD4+ Counts Less Than 200 Cells/mm3

NCT00000712

Conditions
AIDS-Related Opportunistic Infections, Acquired Immunodeficiency Syndrome, Blood-Borne Infections, +20 more
Locations
  • Bmc Actg Crs Boston, Massachusetts, United States
  • Beth Israel Deaconess - East Campus A0102 CRS Boston, Massachusetts, United States
  • Beth Israel Deaconess Med. Ctr., ACTG CRS Boston, Massachusetts, United States
  • Massachusetts General Hospital ACTG CRS Worcester, Massachusetts, United States
View Trial Details
Completed

A Phase I Safety and Immunogenicity Trial of Live Recombinant Canarypox ALVAC-HIV (vCP205) and HIV-1 SF-2 rgp120 in HIV-1 Uninfected Adult Volunteers

NCT00000847

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • UAB AVEG Birmingham, Alabama, United States
  • JHU AVEG Baltimore, Maryland, United States
  • St. Louis Univ. School of Medicine AVEG St Louis, Missouri, United States
  • Univ. of Rochester AVEG Rochester, New York, United States
View Trial Details
Completed

Immunologic and Virologic Consequences of Long-Term Highly Active Antiretroviral Therapy (HAART) in Subjects With Moderately Advanced HIV-1 Disease: A Follow-Up Study to ACTG 315

NCT00000891

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +13 more
Locations
  • Univ of Colorado Health Sciences Ctr Denver, Colorado, United States
  • Rush Presbyterian - Saint Luke's Med Ctr Chicago, Illinois, United States
  • Case Western Reserve Univ Cleveland, Ohio, United States
View Trial Details
Completed

Comparison of New Anti-HIV Drug Combinations in HIV-Infected Children Who Have Taken Anti-HIV Drugs

NCT00001083

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Univ of Alabama at Birmingham - Pediatric Birmingham, Alabama, United States
  • UCSD Med Ctr / Pediatrics / Clinical Sciences La Jolla, California, United States
  • Long Beach Memorial (Pediatric) Long Beach, California, United States
  • Children's Hosp of Los Angeles/UCLA Med Ctr Los Angeles, California, United States
View all 61 locations
View Trial Details
Completed

A Study of 141W94 Used Alone or in Combination With Zidovudine Plus 3TC in HIV-Infected Patients

NCT00001085

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +13 more
Locations
  • Alabama Therapeutics CRS Birmingham, Alabama, United States
  • USC CRS Los Angeles, California, United States
  • University of Colorado Hospital CRS Aurora, Colorado, United States
  • Univ. of Miami AIDS CRS Miami, Florida, United States
View all 15 locations
View Trial Details
Completed

Comparison of Stavudine Used Alone or in Combination With Didanosine in HIV-Infected Children

NCT00000851

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Harbor - UCLA Med. Ctr. - Dept. of Peds., Div. of Infectious Diseases Torrance, California, United States
  • Univ. of Colorado Denver NICHD CRS Aurora, Colorado, United States
  • Univ. of Connecticut Health Ctr., Dept. of Ped. Farmington, Connecticut, United States
  • Connecticut Children's Med. Ctr. Hartford, Connecticut, United States
View all 35 locations
View Trial Details

Related conditions